Urbanski Paul P, Heinz Nicolas, Zacher Michael, Diegeler Anno
Cardiovascular Clinic Bad Neustadt, Bad Neustadt, Germany
Cardiovascular Clinic Bad Neustadt, Bad Neustadt, Germany.
Eur J Cardiothorac Surg. 2015 Jun;47(6):1077-82. doi: 10.1093/ejcts/ezu316. Epub 2014 Aug 20.
The aim of the study was to evaluate whether a complete aortic root replacement using a composite graft with biological valve prosthesis carries a higher early or late postoperative risk than isolated valve replacement.
Between 1998 and 2008, 182 consecutive patients underwent complete aortic root and ascending aorta replacement using a self-assembled composite graft with a biological valve prosthesis located within the vascular tube (modified Bentall procedure). In the same period, 1959 patients received an isolated aortic valve replacement using a biological valve prosthesis. After matching the patients using five variables (sex, age-by 5-year increments, aortic valve defect, concomitant coronary surgery and the year of surgery), 79 perfectly matched pairs were found. Regarding other clinically essential but unmatched preoperative characteristics, there were no relevant differences between the groups.
There was no statistically significant difference in the early postoperative mortality (30-day and/or in-hospital), which was 5.1% (4 patients) in the Root Group (RG) and 3.8% (3 patients) in the Valve Group (VG). The follow-up was complete for all patients and contained 499 patient-years in the RG versus 488 in the VG. In total, there were 23 deaths in each group during the follow-up time, which was 6.2 ± 2.8 years for the RG and 6.2 ± 3.2 years for the VG. Hence, the linearized death rate and actuarial survival at 10 years were almost identical. They were 4.66%/year and 63.2 ± 8.3%, respectively, in the RG; compared with 4.71%/year and 58.5 ± 9.3% in the VG. Also the rates of valve-related morbidities were similar except for the tendency of a lower rate of cerebral embolism in the RG.
Complete aortic root replacement with a biological composite graft can be performed by experienced surgeons with an operative risk similar to that of an isolated biological aortic valve replacement. Starting with comparable operative outcomes, both procedures offer almost identical long-term survival. The rates of valve-related events after complete aortic root replacement and isolated valve replacement are also comparable, apart from cerebral embolism, which seems to be less frequent after aortic root replacement.
本研究旨在评估使用带生物瓣膜假体的复合移植物进行完整主动脉根部置换术与单纯瓣膜置换术相比,术后早期或晚期风险是否更高。
1998年至2008年期间,182例连续患者接受了使用位于血管管内的带生物瓣膜假体的自组装复合移植物进行完整主动脉根部和升主动脉置换术(改良Bentall手术)。同期,1959例患者接受了使用生物瓣膜假体的单纯主动脉瓣膜置换术。使用五个变量(性别、年龄每5年递增、主动脉瓣缺陷、同期冠状动脉手术和手术年份)对患者进行匹配后,发现79对完全匹配的患者。关于其他临床上重要但未匹配的术前特征,两组之间无相关差异。
术后早期死亡率(30天和/或住院期间)无统计学显著差异,根部置换组(RG)为5.1%(4例患者),瓣膜置换组(VG)为3.8%(3例患者)。所有患者均完成随访,RG随访时间为499患者年,VG为488患者年。随访期间每组共有23例死亡,RG随访时间为6.2±2.8年,VG为6.2±3.2年。因此,10年的线性化死亡率和精算生存率几乎相同。RG分别为每年4.66%和63.2±8.3%;VG分别为每年4.71%和58.5±9.3%。除RG中脑栓塞发生率较低的趋势外,瓣膜相关并发症的发生率也相似。
经验丰富的外科医生进行带生物复合移植物的完整主动脉根部置换术时,手术风险与单纯生物主动脉瓣膜置换术相似。从可比的手术结果开始,两种手术的长期生存率几乎相同。除脑栓塞外,完整主动脉根部置换术和单纯瓣膜置换术后瓣膜相关事件的发生率也相当,主动脉根部置换术后脑栓塞似乎较少见。